NDC 0074-3197

Moderiba

Ribavirin

Moderiba is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Ribavirin.

Product ID0074-3197_989a1a4a-ffd5-3783-6e03-ead99c1a4447
NDC0074-3197
Product TypeHuman Prescription Drug
Proprietary NameModeriba
Generic NameRibavirin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2014-01-20
Marketing End Date2019-05-01
Marketing CategoryANDA / ANDA
Application NumberANDA077456
Labeler NameAbbVie Inc.
Substance NameRIBAVIRIN
Active Ingredient Strength200 mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN

Packaging

NDC 0074-3197-16

168 TABLET, FILM COATED in 1 BOTTLE (0074-3197-16)
Marketing Start Date2014-01-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0074-3197-16 [00074319716]

Moderiba TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077456
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-01-20
Marketing End Date2019-05-01

NDC 0074-3197-30 [00074319730]

Moderiba TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077456
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-01-20
Marketing End Date2017-06-30

Drug Details

Active Ingredients

IngredientStrength
RIBAVIRIN200 mg/1

OpenFDA Data

SPL SET ID:7046ff4c-8a75-5fd4-d40f-ff0cc84eed5f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1487498
  • 1486198
  • 1486202
  • 1487500
  • 248109
  • 1486197
  • 1486200
  • 1486203
  • 1298334
  • 757599
  • 597718
  • 754738
  • 757597
  • 597722
  • UPC Code
  • 0300743197167
  • 0300743282566
  • 0300743282146
  • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    NDC Crossover Matching brand name "Moderiba" or generic name "Ribavirin"

    NDCBrand NameGeneric Name
    0074-3197ModeribaRibavirin
    0074-3282ModeribaRibavirin
    0085-1318REBETOLribavirin
    0781-2043RibavirinRibavirin
    0781-5177RibavirinRibavirin
    42494-423RibavirinRibavirin
    53808-0781RibavirinRIBAVIRIN
    53808-0782RibavirinRIBAVIRIN
    54738-950ribavirinribavirin
    54738-951ribavirinribavirin
    54738-952ribavirinribavirin
    54738-953ribavirinribavirin
    63629-2149RibavirinRibavirin
    65841-046RibavirinRibavirin
    65841-129RibavirinRibavirin
    65841-260RibavirinRibavirin
    65841-603RibavirinRibavirin
    65841-632RibavirinRibavirin
    65862-207RibavirinRibavirin
    0187-0007VirazoleRibavirin

    Trademark Results [Moderiba]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    MODERIBA
    MODERIBA
    86089226 4598851 Live/Registered
    AbbVie, Inc.
    2013-10-11

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.